Pete Williams

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Rupali Vohra

Københavns Universitet

DENMARK

View details

James Morgan

Professor

Cardiff University

UNITED KINGDOM

View details

David Garway-Heath

University College London

UNITED KINGDOM

View details

Helder André

Karolinska Institutet

SWEDEN

View details

Peter van Wijngaarden

Associate Professor

University of Melbourne

AUSTRALIA

View details

Revathi Balasubramanian

Assistant Professor

Columbia University Irving Medical Center

UNITED STATES

View details

Romanas Chaleckis

Assistant Professor

Nagoya University

JAPAN

View details

James Tribble

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pete Williams

Research Interests

Explore related searches

Contact this professor

Articles (20)

Pyrroloquinoline quinone: a potential neuroprotective compound for neurodegenerative diseases targeting metabolism

NMNAT2 is a druggable target to drive neuronal NAD production

Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume

Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma

Glycolysis and glucose metabolism as a target for bioenergetic and neuronal protection in glaucoma

Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss

Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection

Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering

Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters

Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotection

When is a control not a control? Reactive microglia occur throughout the control contralateral pathway of retinal ganglion cell projections in experimental glaucoma

Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma

Retinal Ganglion Cell Degeneration in a Rat Magnetic Bead Model of Ocular Hypertensive Glaucoma.

Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer’s disease

Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: A crossover randomized clinical trial

Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin.

Complement peptide C3a receptor 1 promotes optic nerve degeneration in DBA/2J mice

Potential Therapeutic Benefit of NAD+ Supplementation for Glaucoma and Age-Related Macular Degeneration

OPA1 deficiency accelerates hippocampal synaptic remodelling and age-related deficits in learning and memory

Ocular hypertension suppresses homeostatic gene expression in optic nerve head microglia of DBA/2 J mice.

Collaborators (8)

Rupali Vohra

James Morgan

David Garway-Heath

Helder André

Peter van Wijngaarden

Revathi Balasubramanian

Romanas Chaleckis

James Tribble

Make your next move.